Put PDE5 Inhibitor Risks in Perspective
June 2022
More data linking PDE5 inhibitors (sildenafil, etc) to eye problems will raise questions about safety.
Labels already warn of rare optic neuropathy...which can cause loss of vision that may be permanent.
New evidence suggests that this and other serious eye conditions (retinal detachment, etc) occur in about 16 in 10,000 patients per year on a PDE5 inhibitor...higher than prior estimates.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive